Ginkgo Bioworks Holdings Quick Ratio 2020-2022 | DNA
Historical quick ratio values for Ginkgo Bioworks Holdings (DNA) over the last 10 years.
| Ginkgo Bioworks Holdings Quick Ratio Historical Data |
| Date |
Current Assets - Inventory |
Current Liabilities |
Quick Ratio |
| 2022-12-31 |
$1.45B |
$0.17B |
8.36 |
| 2022-09-30 |
$1.46B |
$0.13B |
11.67 |
| 2022-06-30 |
$1.59B |
$0.14B |
11.78 |
| 2022-03-31 |
$1.70B |
$0.16B |
10.66 |
| 2021-12-31 |
$1.72B |
$0.14B |
12.76 |
| 2021-09-30 |
$1.81B |
$0.09B |
20.01 |
| 2021-06-30 |
$0.00B |
$0.01B |
0.00 |
| 2021-03-31 |
$0.00B |
$0.00B |
0.00 |
| 2020-12-31 |
$0.00B |
|
0.00 |
| 2020-09-30 |
$0.00B |
|
0.00 |
| 2019-12-31 |
$0.00B |
|
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$2.549B |
$0.478B |
|
Ginkgo Bioworks platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo Bioworks, formerly known as Soaring Eagle Acquisition Corp., is based in NEW YORK.
|
